Dergiler / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 4

Impaired quality of life in patients with intermittent atrial fibrillation

Sayfa
250–255
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The impairment of subjective health-related QoL is worse in patients with intermittent AF

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The quality of life (QoL) is impaired in patients with atrial fibrillation (AF).
📊
Temel Bulgular & Veri:Methods: The study was designed as an observational cross-sectional study, and 135 consecutive patients with documented AF admitted to the cardiology outpatient clinic in a tertiary hospital were recruited.
💡
Sonuç & Katkı:The impairment of subjective health-related QoL is worse in patients with intermittent AF
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: The quality of life (QoL) is impaired in patients with atrial fibrillation (AF). However, the data on the perceived QoL of patients with different types of AF is limited. In this study, we investigated the QoL of patients with intermittent and chronic AF. Methods: The study was designed as an observational cross-sectional study, and 135 consecutive patients with documented AF admitted to the cardiology outpatient clinic in a tertiary hospital were recruited. The pattern of AF was classified as intermittent or chronic AF. The European Heart Rhythm Association (EHRA) classification and symptom severity score were used to quantify the symptoms related to AF. The QoL was assessed by the Short Form-36 and the Canadian Cardiovascular Society Severity in Atrial Fibrillation (SAF) scale.Results: Thirty-nine percent of the patients (n=52) had intermittent AF and 61% (n=83) had chronic AF. In the overall patient population, 92% reported having at least one of the symptoms that can be attributable to AF. Although the prevalence of symptoms were similar in patients with intermittent or chronic AF, the patients with intermittent AF perceived more severe palpitations (symptom severity score 2.4±1.7 vs. 1.5±1.5, p=0.003). Patients with intermittent AF had higher EHRA and SAF scores than the patients with chronic AF (2.6±0.9 vs. 1.9±0.8, p<0.001; 2.5±1.3 vs. 1.7±1.2, p<0.001, respectively). Conclusion: Outpatients with AF have a high prevalence of symptoms and impaired QoL. The impairment of subjective health-related QoL is worse in patients with intermittent AF

🔖

Bu Makaleye Atıf Yap

NAZLI, C., EREN, N. K., TÜLÜCE, S. Y., KOÇAĞRA, G. İ. Y., KILIÇASLAN, B., KOCABAŞ, U. (2016). Impaired quality of life in patients with intermittent atrial fibrillation. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 4, 250–255. https://ajindex.com/articles/365877

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al. Guidelines for the management of atrial fibrilla- tion: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Euro Heart J 2010; 31: 2369- 429. Ertaş F, Kaya H, Yüksel M, Soydinç MS, Alan S, Ülgen MS. Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER) study design. Anatol J Cardiol 2013; 13: 339-43.
  2. Ertaş F, Eren NK, Kaya H, Arıbaş A, Acar G, KanadaşıM, et al; AFTER Investigators. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER). Cardiol J 2013; 20: 447-52.
  3. Uyarel H, Onat A, Yüksel H, Can G, Ordu S, Dursunoğlu D. Incidence, prevalence and mortality estimates for chronic atrial fibrillation in Turkish adults. Turk Kardiol Dern Ars 2008; 36: 214-22.
  4. Kepez A, Erdoğan O. Anticoagulation for non-valvular atrial fibrilla- tion: new anticoagulant agents. Anatol J Cardiol 2013; 13: 379-84.
  5. Karaçağlar E, Atar I, Yetiş B, Corut H, Ersoy B, Yılmaz K, et al. The frequency of embolic risk factors and adequacy of anti-embolic treatment in patients with atrial fibrillation: a single tertiary center experience. Anatol J Cardiol 2012; 12: 384-90.
  6. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-33.
  7. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-40.
  8. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-77.
  9. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36: 1303-9.
  10. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006; 119: 448. e1-19. Jenkins LS, Bubien RS. Quality of life in patients with atrial fibrilla- tion. Cardiol Clin 1996; 14: 597-606.
  11. Groenveld HF, Crijns HJ, Van den Berg MP, Van S